These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19064960)

  • 1. Small molecule tyrosine kinase inhibitor and depression.
    Quek R; Morgan JA; George S; Butrynski JE; Polson K; Meyer F; Demetri GD; Block SD
    J Clin Oncol; 2009 Jan; 27(2):312-3. PubMed ID: 19064960
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surgical treatment of relapsing metastatic stromal tumor of the gastrointestinal tract].
    Stilidi IS; Arkhiri PP; Nikulin MP
    Vopr Onkol; 2011; 57(4):508-12. PubMed ID: 22191244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial acneiform rash associated with sorafenib.
    Fleta-Asín B; Vañó-Galván S; Ledo-Rodríguez A; Truchuelo-Díez M; Jaén-Olasolo P
    Dermatol Online J; 2009 Apr; 15(4):7. PubMed ID: 19450400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Targeted therapy of sarcomas].
    Cassier PA; Dufresne A; El Sayadi H; Pissaloux D; Alberti L; Decouvelaere AV; Ranchere D; Ray-Coquard I; Blay JY
    Bull Cancer; 2008 Oct; 95(10):963-74. PubMed ID: 19004727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective neoadjuvant therapy prior to metastasectomy: a new paradigm.
    Schulick RD
    Ann Surg; 2007 Mar; 245(3):353-4. PubMed ID: 17435540
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of tyrosine kinase inhibitors used for gastrointestinal stromal tumors.
    Chintalgattu V; Patel SS; Khakoo AY
    Hematol Oncol Clin North Am; 2009 Feb; 23(1):97-107, viii-ix. PubMed ID: 19248973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.
    Renouf DJ; Wilson L; Blanke CD
    Clin Cancer Res; 2009 Jun; 15(12):3908-11. PubMed ID: 19509180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of imatinib mesylate in treatment for dermatofibroma protuberans].
    Moiseenko VM; Chudenko VA; Orlova RV; Imianitov EN; Matsko DE; Gafton GI; Kochnev VA; Protsenko SA; Mikhaĭlichenko TD; Nogaeva TKh
    Vopr Onkol; 2008; 54(5):656-60. PubMed ID: 19069485
    [No Abstract]   [Full Text] [Related]  

  • 9. Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors.
    Li J; Wang M; Zhang B; Wu X; Lin TL; Liu XF; Zhou Y; Zhang XH; Xu H; Shen LJ; Zou J; Lu P; Zhang D; Gu WJ; Zhang MX; Pan J; Cao H;
    World J Gastroenterol; 2018 Dec; 24(46):5189-5202. PubMed ID: 30581268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation.
    Potenza L; Volzone F; Riva G; Soverini S; Martinelli S; Iacobucci I; Gnani A; Barozzi P; Forghieri F; Morselli M; Zanetti E; Maccaferri M; Baccarani M; Martinelli G; Torelli G; Luppi M
    Br J Haematol; 2009 Jul; 146(2):227-30. PubMed ID: 19545285
    [No Abstract]   [Full Text] [Related]  

  • 11. [GIST: our experience].
    Rossi MT; Fasano G; Morlino A; Scutari F
    G Chir; 2009; 30(1-2):41-5. PubMed ID: 19272232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New treatments for sarcoma.
    Judson I
    Clin Adv Hematol Oncol; 2010 Apr; 8(4):244-6. PubMed ID: 20505647
    [No Abstract]   [Full Text] [Related]  

  • 13. Crizotinib in anaplastic large-cell lymphoma.
    Gambacorti-Passerini C; Messa C; Pogliani EM
    N Engl J Med; 2011 Feb; 364(8):775-6. PubMed ID: 21345110
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastrointestinal stromal tumors (GISTs): a pathology view point.
    Sornmayura P
    J Med Assoc Thai; 2009 Jan; 92(1):124-35. PubMed ID: 19260254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strategy for patients with GIST after failure of imatinib].
    Abe S; Kubota T
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):540-3. PubMed ID: 19381023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitors of tyrosine kinase: waiting for the good news in colorectal cancer as well.
    Sobrero A; Andretta V
    Onkologie; 2008 May; 31(5):224-5. PubMed ID: 18497509
    [No Abstract]   [Full Text] [Related]  

  • 17. The era of targeted therapies: increasing role for novel oncologic drugs in dermatology.
    Montella L; Palmieri G; Lacouture M
    Arch Dermatol; 2007 Jun; 143(6):788-9. PubMed ID: 17576948
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors].
    Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):801-806. PubMed ID: 31550816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
    Wong KK; Fracasso PM; Bukowski RM; Lynch TJ; Munster PN; Shapiro GI; Jänne PA; Eder JP; Naughton MJ; Ellis MJ; Jones SF; Mekhail T; Zacharchuk C; Vermette J; Abbas R; Quinn S; Powell C; Burris HA
    Clin Cancer Res; 2009 Apr; 15(7):2552-8. PubMed ID: 19318484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which tyrosine kinase inhibitor, if any?
    Ruiz-Arguelles GJ
    Clin Adv Hematol Oncol; 2011 Nov; 9(11):878-9. PubMed ID: 22252622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.